Teriparatide (Forteo) for Osteoporosis

Research output: Contribution to journalShort surveypeer-review

4 Scopus citations


Teriparatide (Forteo) is a synthetic human parathyroid hormone labeled for use in men and postmenopausal women with osteoporosis who are at high risk of fractures. It activates osteoblasts to stimulate new bone formation.

Original languageEnglish (US)
Pages (from-to)1983-1984
Number of pages2
JournalAmerican family physician
Issue number8
StatePublished - Apr 15 2004

ASJC Scopus subject areas

  • Family Practice


Dive into the research topics of 'Teriparatide (Forteo) for Osteoporosis'. Together they form a unique fingerprint.

Cite this